应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NVOX 2倍做多NVO ETF-Defiance
盘后交易 09-28 19:25:27 EDT
9.81
-0.06
-0.61%
盘后
9.81
+0.00
0.00%
19:07 EDT
最高
9.92
最低
9.59
成交量
31.38万
今开
9.65
昨收
9.87
日振幅
3.34%
总市值
3,589万
流通市值
3,589万
总股本
365.81万
成交额
304.90万
换手率
8.58%
流通股本
365.81万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
诺和押注下一发展篇章,礼来在GLP‑1领域持续扩大优势
环球市场播报 · 09-25
诺和押注下一发展篇章,礼来在GLP‑1领域持续扩大优势
美股异动 | 医药股上涨,礼来涨近4%
老虎资讯综合 · 09-24
美股异动 | 医药股上涨,礼来涨近4%
美股医药股逆市走高,礼来涨近4%,辉瑞涨超2%,默沙东、强生涨近2%,诺华制药、诺和诺德涨超1%;AI医疗概念股Temp
智通财经 · 09-24
美股医药股逆市走高,礼来涨近4%,辉瑞涨超2%,默沙东、强生涨近2%,诺华制药、诺和诺德涨超1%;AI医疗概念股Temp
诺和新战略成败取决于一件它无法生产的东西:投资者信任
环球市场播报 · 09-24
诺和新战略成败取决于一件它无法生产的东西:投资者信任
A股节前全天缩量震荡 深成指收跌2.34% 减肥药、电子烟板块疲软
金吾财讯 · 09-24
A股节前全天缩量震荡 深成指收跌2.34% 减肥药、电子烟板块疲软
诺和诺德(NVO)瞄准脱发市场 推进后Wegovy多元化增长战略
金吾财讯 · 09-23
诺和诺德(NVO)瞄准脱发市场 推进后Wegovy多元化增长战略
字节、百度与恒瑞、诺和诺德,抢滩AI制药商业化
蓝鲸财经 · 09-23
字节、百度与恒瑞、诺和诺德,抢滩AI制药商业化
诺和诺德考虑改变美股上市方式:拟告别ADR、直接登陆纽交所
老虎资讯综合 · 09-23
诺和诺德考虑改变美股上市方式:拟告别ADR、直接登陆纽交所
诺和诺德对升级其纽约上市地位的想法持开放态度,这是这家丹麦减肥药制造商提升其在美国知名度努力的一部分,其英国竞争对手阿斯
智通财经 · 09-23
诺和诺德对升级其纽约上市地位的想法持开放态度,这是这家丹麦减肥药制造商提升其在美国知名度努力的一部分,其英国竞争对手阿斯
Viking Therapeutics涨超35%!减肥药传来捷报:给药频率减半仍维持97%减重
智通财经 · 09-22
Viking Therapeutics涨超35%!减肥药传来捷报:给药频率减半仍维持97%减重
诺和诺德CEO:对收购持开放态度,以强化减重药物管线
格隆汇 · 09-22
诺和诺德CEO:对收购持开放态度,以强化减重药物管线
诺和诺德资本市场日遇冷:CEO坦言承诺太多、兑现不足,必须重建投资者信心
智通财经 · 09-22
诺和诺德资本市场日遇冷:CEO坦言承诺太多、兑现不足,必须重建投资者信心
诺和诺德(NVO)CagriSema减重效果胜过礼来(LLY)低剂量Zepbound
金吾财讯 · 09-22
诺和诺德(NVO)CagriSema减重效果胜过礼来(LLY)低剂量Zepbound
诺和诺德CEO:正在成瘾等领域测试GLP-1药物。
智通财经 · 09-22
诺和诺德CEO:正在成瘾等领域测试GLP-1药物。
减肥药巨头,裁掉了1.3万个岗位
第一财经 · 09-21
减肥药巨头,裁掉了1.3万个岗位
减肥药巨头诺和诺德本轮调整,裁掉了1.3万个岗位
第一财经 · 09-21
减肥药巨头诺和诺德本轮调整,裁掉了1.3万个岗位
诺和诺德(NVO)跌4.81% 司美格鲁肽被关联罕见致盲眼疾
金吾财讯 · 09-21
诺和诺德(NVO)跌4.81% 司美格鲁肽被关联罕见致盲眼疾
诺和诺德再向礼来“宣战”!CagriSema头对头胜过替尔泊肽,减重12.4%
华尔街见闻 · 09-21
诺和诺德再向礼来“宣战”!CagriSema头对头胜过替尔泊肽,减重12.4%
注射明星减肥药或导致失明?礼来和诺和诺德两巨头在美遭患者起诉
智通财经 · 09-21
注射明星减肥药或导致失明?礼来和诺和诺德两巨头在美遭患者起诉
注射明星减肥药或导致失明?礼来和诺和诺德两巨头在美遭患者起诉
澎湃新闻 · 09-21
注射明星减肥药或导致失明?礼来和诺和诺德两巨头在美遭患者起诉
加载更多
公司概况
公司名称:
2倍做多NVO ETF-Defiance
所属市场:
ARCA
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"2倍做多NVO ETF-Defiance","latestPrice":9.81,"timestamp":1790625600000,"preClose":9.87,"halted":0,"volume":313843,"hourTrading":{"tag":"盘后","latestPrice":9.81,"preClose":9.81,"latestTime":"19:07 EDT","volume":5458,"amount":53593.79398,"timestamp":1790636823184,"change":0,"changeRate":0,"amplitude":0.005892},"delay":0,"changeRate":-0.006079027355622971,"floatShares":3658101,"shares":3658101,"eps":0,"marketStatus":"盘后交易","change":-0.06,"latestTime":"09-28 19:25:27 EDT","open":9.65,"high":9.92,"low":9.59,"amount":3049049.082815,"amplitude":0.033435,"askPrice":9.94,"askSize":700,"bidPrice":9.77,"bidSize":400,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1790640000000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":9.87,"sharesOutstanding":4128101,"nav":9.8,"aum":35849389.8,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":9.64,"preClose":9.87,"latestTime":"09:27 EDT","volume":17013,"amount":165285.07188600002,"timestamp":1790602058674,"change":-0.23,"changeRate":-0.023303,"amplitude":0.018237},"postHourTrading":{"tag":"盘后","latestPrice":9.81,"preClose":9.81,"latestTime":"19:07 EDT","volume":5458,"amount":53593.79398,"timestamp":1790636823184,"change":0,"changeRate":0,"amplitude":0.005892},"volumeRatio":0.277259,"impliedVol":0.6173,"impliedVolPercentile":0.092},"requestUrl":"/m/hq/s/NVOX","defaultTab":"news","newsList":[{"id":"2670447830","title":"诺和押注下一发展篇章,礼来在GLP‑1领域持续扩大优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2670447830","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670447830?lang=zh_cn&edition=full","pubTime":"2026-09-25 19:45","pubTimestamp":1790336700,"startTime":"0","endTime":"0","summary":"与此同时,礼来持续蚕食诺和诺德的市场地位,包括快速兴起的口服减肥药赛道。就在诺和诺德努力扭转颓势之际,部分分析师认为,礼来手握多项优势,有望稳固其在肥胖药市场龙头的位置。诺和诺德的口服 Wegovy 片剂抢先上市,比礼来竞品 Foundayo 早数月,公司希望借此守住口服减重赛道的先发优势。礼来 8 月披露,其二季度在美国 GLP1 市场份额约61%,诺和诺德约39%。里辛格称,礼来拥有下一代肥胖药管线,有望在 Zepbound 和 Foundayo 之外继续扩大领先优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-25/doc-iniszvzv7702421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4533","LU2471134879.HKD","CURE","OZEM","LU0058720904.USD","LU2471134796.USD","LU0097036916.USD","LU2491050154.USD","NVOC","LU0109394709.USD","LU0289739699.SGD","IYH","SG9999014898.SGD","LU1712237335.SGD","SG9999014880.SGD","LU0823434740.USD","LU2237443465.HKD","LU2471134523.USD","LU0417517546.SGD","IE00BWXC8680.SGD","LU2462591350.SGD","FHLC","LU0786609619.USD","LU2063271972.USD","IE0009355771.USD","LU2471134952.CNY","LU2468319806.SGD","LU1868836914.USD","LU2746668974.SGD","IE00B2B36J28.USD","LU1989771016.USD","BK4532","LU1629891620.HKD","IE00BFSS7M15.SGD","LU2111349929.HKD","LU0471298777.SGD","SG9999015945.SGD","SG9999015952.SGD","LU0114720955.EUR","SGXZ51526630.SGD","LU0158827948.USD","GDOC","SGXZ81514606.USD","IE00BKDWB100.SGD","LU0198837287.USD","LU1232071149.USD","LU0823416689.USD","LU0061475181.USD","IE00BJT1NW94.SGD","LU0683600562.USD","LU2552382058.USD","SGXZ99366536.SGD","LU2023251221.USD","LU0094547139.USD","LU2746668461.USD","LU2361044949.HKD","LU2028103732.USD","LU0174119429.USD","SG9999001176.USD","LU0109391861.USD","LU0689472784.USD","PPH","THNR","TRUH","JDOC","IE0005OL40V9.USD","SG9999015986.USD","LU0320765059.SGD","LU1069344957.HKD","LU1057294990.SGD","SG9999018865.SGD","LU0266013472.USD","LU0889565916.HKD","LU1093756325.SGD","LU0225283273.USD","LU1366192091.USD","IE00BJLML261.HKD","LU2491050071.SGD","MHIP","ELIL","IE00BFTCPJ56.SGD","LU0672654240.SGD","LU2237438978.USD","LU1691799644.USD","BK4007","IE0001KFT4U8.USD","LU2089984988.USD","LU0234572021.USD","IE00B7KXQ091.USD","LU0882574139.USD","ILDR","SGXZ31699556.SGD","LU2168564495.EUR","LU2168564065.EUR","LU2023250504.SGD","LU2023250330.USD","PJP","FTXH","LU1551013425.SGD","LU1267930730.SGD","LU2106854487.HKD","LU2552382215.SGD","IE00BK4W5L77.USD","LU0640476718.USD","LU2265009873.SGD","BK4588","LU2417539215.USD","LLYZ","SG9999015978.USD","IE00BK4W5M84.HKD","LU0823434583.USD","LU1988902786.USD","LU2112291526.USD","MEDX","WDNA","LU2756315664.SGD","LU0203201768.USD","LU0456855351.SGD","LU1983299246.USD","IE0004445239.USD","LLII","LU0210536198.USD","LU0708995401.HKD","LU0238689110.USD","BK4516","LU2461242641.AUD","LU1127390331.HKD","LU2213496289.HKD","LU1979441026.SGD","BK4534","LU2168564222.USD","IE00B1XK9C88.USD","LU1323610961.USD","LU1868836757.USD","LU2236285917.USD","LU0079474960.USD","LU1023059063.AUD","GB00BDT5M118.USD","LU0345770308.USD","LU2237443978.SGD","LU0203202063.USD","LU0820561818.USD","CANC","SG9999001176.SGD","LU2750360641.GBP","LU1868837136.USD","LU0133085943.USD","IXJ","LU0256863902.USD","LU1061106388.HKD","IE00BJJMRY28.SGD","LU0345770993.USD","LU0158827781.USD","LU1145028129.USD","LU2361044865.SGD","MEDI","LU0006306889.USD","LU2264538146.SGD","RXL","XLV","BK4581","BK4585","IE00BFSS8Q28.SGD","LU0385154629.USD","LU1974910355.USD","LLY","LU2089283258.USD","LU1868837300.USD","LU2491049909.HKD","LU0106261372.USD","IE00B1BXHZ80.USD","NVOH","LU0354030438.USD","IE0002141913.USD","LU1551013342.USD","LU2237443622.USD","LU2750360997.AUD","BK4599","LU1917777945.USD","LU2271345857.HKD","LU1548497426.USD","SG9999017495.SGD","LU0787776722.HKD","LU1814569148.SGD","SG9999013999.USD","LU1868836591.USD","SG9999014914.USD","LU0466842654.USD","TMED","LU0323591593.USD","NVO","LU2108987350.USD","IE00B4JS1V06.HKD","LU0096364046.USD","LU2211815571.USD","IE00BKPKM429.USD","HRTS","LU0353189680.USD","LLYX","ELIS","LU1291159041.SGD","LU0353189763.USD","LU2552382132.HKD","LU0820562030.AUD","LU2168563687.JPY","LU2462157665.USD","LU2360106947.USD","LU0964807845.USD","LU0882574055.USD","LU2324357040.USD","IE00BKVL7J92.USD","SGXZ57979304.SGD","IE00BZ1G4Q59.USD","SG9999018857.SGD","NVOX","LU1804176565.USD","AGNG","LU0943347566.SGD","LU1035775433.USD","LU0256863811.USD","LU2237443895.HKD","VHT","LU2896262040.SGD","IE00B775H168.HKD","IE00BN29S564.USD","LU1064131342.USD","LU2168564149.EUR","LU2756315318.SGD","LU2361045086.USD","LU0154236417.USD","LU1623119135.USD","LU2237443382.USD","LU0122379950.USD","LU0820561909.HKD","LU0471298694.HKD","LU0320765992.SGD","IHE","LU2087625088.SGD","LU1093756168.USD","LU2602419157.SGD","LU1720051108.HKD","IE0004445015.USD","LU0354030511.USD","LU1280957306.USD","LU1720051017.SGD","LU2089284900.SGD","LU2357305700.SGD","LU2237443549.SGD","LU2456880835.USD","SG9999014906.USD","IE00BJJMRX11.SGD","LU0316494557.USD","LU0432979614.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159199811","title":"美股异动 | 医药股上涨,礼来涨近4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159199811","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159199811?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:23","pubTimestamp":1790259829,"startTime":"0","endTime":"0","summary":"9月24日,美股医药股上涨,礼来涨近4%,辉瑞涨超2%,默沙东、强生涨近2%,诺华、诺和诺德涨超1%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0942090050.USD","NVOX","LU1989772840.SGD","SG9999018857.SGD","LU0823434583.USD","BK4585","LU1934455277.USD","BK4588","ELIS","IE00B3PB1722.GBP","BK4568","LU0889565916.HKD","SG9999014567.USD","LU1720051017.SGD","LU0466842654.USD","PFE","IE00BLSP4452.SGD","JDOC","LU0225283273.USD","LU2168563687.JPY","SG9999015341.SGD","SG9999014559.SGD","LU1929549753.HKD","AGNG","LU2237443622.USD","LU0109394709.USD","LU2168564222.USD","SG9999002232.USD","LU0234570918.USD","SG9999003800.SGD","IE00BKDWB100.SGD","SG9999017495.SGD","LU0861579265.USD","LU0289961442.SGD","CURE","IE00BFSS8Q28.SGD","LU2125154935.USD","LU1066051498.USD","IE00B42XCP33.USD","XLV","LU0133085943.USD","LU2430703178.SGD","LU1894683264.USD","IE0004445015.USD","LU0672654240.SGD","RXL","LU0545562505.USD","LU0345770308.USD","LU2168564065.EUR","LU1116320737.USD","LU2750360641.GBP","LU0943347566.SGD","LU0471298694.HKD","LU0225771236.USD","LU0170899867.USD","LU2125909593.SGD","LU0545039389.USD","LU2491050071.SGD","LU0320765992.SGD","LU0162691827.USD","LU2237443549.SGD","LU1720051108.HKD","LU1430594728.SGD","LU0708995401.HKD","LU0158827781.USD","LU1674673428.USD","IE00B7SZLL34.SGD","LU2417539215.USD","IE000BZT7R73.USD","IE000M9KFDE8.USD","SG9999015986.USD","LU1623119135.USD","LU0225284248.USD","LU1064131342.USD","LU2462157665.USD","LU0114720955.EUR","LU1778281490.HKD","IE00BWXC8680.SGD","IE0034235303.USD","LU0321505439.SGD","SG9999014898.SGD","LU0256863902.USD","LU2237443382.USD","LU0122379950.USD","LU1127390331.HKD","LU1093756168.USD","BK4533","BK4007","LU0097036916.USD","LU0265550946.USD","LU1804176565.USD","SG9999011175.SGD","LU1934455194.USD","IE00BKPKM429.USD","LU2756315318.SGD","PAWZ","LU1629891620.HKD","LU1894683348.USD","LU2552382058.USD","LU2552382132.HKD","LU2357305700.SGD","LU1917777945.USD","SG9999015358.SGD","LLII","LU0795875169.SGD","LU0345769631.USD","LU1868837300.USD","LU1244550221.USD","LU0553294199.USD","LU1145028129.USD","IE0001KFT4U8.USD","LU0320765646.SGD","BK7095","LU0072461881.USD","LU1732799900.SGD","LU0354030511.USD","LU1074936037.SGD","LU1506573853.SGD","LU1868836914.USD","LU1032955483.USD","IE00BVYPNW00.USD","LU0061475181.USD","SG9999014914.USD","LU1941712348.USD","BK4532","LU2361044865.SGD","LU0203202063.USD","LU0070302665.USD","LU0320765059.SGD","LU0345769128.USD","LU2491050154.USD","SG9999018865.SGD","IE0002141913.USD","LU0070217475.USD","IXJ","LU0738911758.USD","LU0965509010.AUD","LU2111349929.HKD","LU2456880835.USD","LU1814569148.SGD","LU2106854487.HKD","LU1366192091.USD","VHT","LU0471298777.SGD","BK4550","JNJ","BK1574","MHIP","LU1974910355.USD","LU1244550494.USD","LU0096364046.USD","LU0426412945.USD","LU0786609619.USD","LU0203347892.USD","LU0787776722.HKD","LU0058720904.USD","LLYZ","LU0174119429.USD","LU2265009873.SGD","LU2487616109.SGD","LU2471134952.CNY","LU0882574055.USD","BK1161","LU0949170772.SGD","HRTS","IE0004445239.USD","SGXZ81514606.USD","SG9999014906.USD","LU0820561818.USD","LU0456855351.SGD","LU1914381329.SGD","IE00BSNM7G36.USD","LU2471134523.USD","LU2756315664.SGD","LU1323610961.USD","LU0234572021.USD","LU2361044949.HKD","LU0006306889.USD","LU1232071149.USD","NVOH","LU1043141123.HKD","LU2896262040.SGD","LU2023250330.USD","LU0964807845.USD","MEDX","IE00BVYPNV92.GBP","LU0426417589.USD","LU2430703251.USD","LU0889566641.SGD","SG9999001176.SGD","LU0106261372.USD","TRUH","SGXZ99366536.SGD","LU0289739343.SGD","LU1066051225.USD","LU0208291251.USD","IE00B3T34201.USD","LU1551013425.SGD","CANC","LU0640476718.USD","LU1201861249.SGD","WDNA","IE00BJT1NW94.SGD","SGXZ31699556.SGD","LU2112291526.USD","LU0265550359.USD","IE000SO60NU8.SGD","IE00BBT3K403.USD","LU2213496289.HKD","LU2028103732.USD","LU2089283258.USD","BK4578","LU2271345857.HKD","LU0316494557.USD","LU2087625088.SGD","SG9999015945.SGD","LU1291159041.SGD","BK4516","LU0472753341.HKD","LU0432979614.USD","IE00BJLML261.HKD","LU1035775433.USD","LU1196500208.SGD","THNR","LU2237443895.HKD","LU1043141396.HKD","IE00B4R5TH58.HKD","LU2264538146.SGD","SG9999015952.SGD","LU1979441026.SGD","LU2592432038.USD","IE00B775H168.HKD","LU0792757196.USD","LU0511384066.AUD","LU2468319806.SGD","LU2403377893.USD","LU0965509101.SGD","LU2596442595.SGD","LU1718418525.SGD","LU1261432733.SGD","IE00BJJMRZ35.SGD","LU1941712264.USD","BK4504","LU0823434740.USD","LU0965508806.USD","LU0912757837.SGD","LU2433249047.HKD","LU1121112475.USD","LU1699723380.USD","OZEM","LU2347655156.SGD","LU0321505868.SGD","SGXZ51526630.SGD","LU0079474960.USD","IE00BJJMRX11.SGD","LU1712237335.SGD","LU2023250504.SGD","BK4599","LU1923622614.USD","IE0009355771.USD","LU0094547139.USD","LU0124676726.USD","LU1868837136.USD","LU0683600562.USD","BK4559","LU0306806265.USD","BK1515","LU2129689605.HKD","SGXZ57979304.SGD","LU1244550577.SGD","NVO","MRK","IE00BJJMRY28.SGD","LU2360032135.SGD","LU0661504455.SGD","LABD","LU0256863811.USD","LU2063271972.USD","SG9999001176.USD","IE00BDGV0183.EUR","LU0689626769.HKD","LU0203201768.USD","LU0210528500.USD","LU1069344957.HKD","LU1935042991.SGD","LU0098860793.USD","LU0882574139.USD","BGIA","BK4534","LU1057294990.SGD","IE00BN8TJ469.HKD","LU2357627491.SGD","LU2746668461.USD","LU0354030438.USD","IE00BFTCPJ56.SGD","LU2505996509.AUD","LU2236285917.USD","LU1162221912.USD","IHE","LU1571399168.USD","LU0417517546.SGD","ILDR","LU0345770993.USD","LU0820562030.AUD","LU0868494617.USD","LU0154236417.USD","LU2491049909.HKD","LU2129689431.USD","LU0053666078.USD","LU1066051811.HKD","159938","LU0109391861.USD","LU2361045086.USD","LU2750360997.AUD","LU1883839398.USD","LU2211815571.USD","SG9999015978.USD","LU1069347547.HKD","SGXZ80539844.SGD","LU1674673691.USD","IE000MB6IJN5.SGD","LLY","LU2023251221.USD","LU0795875086.SGD","LU1691799644.USD","LU2602419157.SGD","LU1037948541.HKD","LU1585245621.USD","LU0211331839.USD","BK4592","LU0648001328.SGD","LU2237438978.USD","LU0289739699.SGD","LU0069063385.USD","IE00B1BXHZ80.USD","IE000WAW04H5.SGD","LU0130517989.USD","LU0689472784.USD","IE0002270589.USD","ELIL","LU0820561909.HKD","LU1989771016.USD","IE00B19Z3B42.SGD","LU1267930813.SGD","LU0985481810.HKD","LU0994945656.USD","IE00B7KXQ091.USD","SG9999002224.SGD","LU2108987350.USD","LU1732800096.USD","GDOC","LU2471134879.HKD","LU2746668974.SGD","LU1023059063.AUD","SG9999013999.USD","LU2089284900.SGD","LU1061106388.HKD","PPH","IE00BZ1G4Q59.USD","NVS","LU0859254822.USD","LU2168564495.EUR","LU2462591350.SGD","LU1003077747.HKD","FHLC","LU2471134796.USD","IE0005OL40V9.USD","LU2552382215.SGD","LU0057025933.USD","BK4581","LU0320765489.SGD","LU1868836591.USD","LU2168564149.EUR","LU2360106947.USD","TMED","SG9999014542.SGD","LU2125154778.USD","LU2324357040.USD","LU2125909247.SGD","LU0823416689.USD","LU1035773651.USD","LU1032466523.USD","LU0203345920.USD","LU0353189680.USD","LU0965509283.SGD","IE00B1XK9C88.USD","PJP","LU2505996681.GBP","SG9999001440.SGD","IE00BLSP4239.USD","LU1228905037.USD","SG9999014880.SGD","LU0266013472.USD","BMED","LU2133065610.SGD","LU1551013342.USD","GB00BDT5M118.USD","LU2461242641.AUD","LU1228905540.USD","LU2129689514.USD","LU1066053197.SGD","IE00BKVL7J92.USD","SG9999014575.USD","LU1934455863.HKD","IE00BFSS7M15.SGD","LU0198837287.USD","LU0353189763.USD","LU1868836757.USD","LU2089984988.USD","LU0306807586.USD","LU1221951046.USD","LU0385154629.USD","LU1267930730.SGD","IE00BGHQF631.EUR","IE00BK4W5M84.HKD","LU2237443978.SGD","LU1116320901.HKD","LU0477156953.USD","BK7104","LU0238689110.USD","IYH","IE00B2B36J28.USD","LU1989772923.USD","FTXH","LU1221951129.SGD","LU0985320562.USD","IE00B4JS1V06.HKD","LU1548497426.USD","LU0130102774.USD","LU0210536198.USD","IE00BFXG1179.USD","IE00BK4W5L77.USD","LU1496350502.SGD","NVOC","IE000F7OJYX1.SGD","IE00BN29S564.USD","MEDI","LU0868494708.USD","IE0000B7K699.USD","LU1059921491.USD","LU0158827948.USD","IE00B19Z3581.USD","LU2023250843.SGD","LLYX","LU1037948897.HKD","LU0980610538.SGD","LU2237443465.HKD","LU1988902786.USD","LU1983299246.USD","LU1093756325.SGD","LU2430703095.HKD","LU1280957306.USD","LU0323591593.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669496056","title":"美股医药股逆市走高,礼来涨近4%,辉瑞涨超2%,默沙东、强生涨近2%,诺华制药、诺和诺德涨超1%;AI医疗概念股Temp","url":"https://stock-news.laohu8.com/highlight/detail?id=2669496056","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669496056?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:19","pubTimestamp":1790259582,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0266013472.USD","LU0432979614.USD","LLYZ","LU1629891620.HKD","LU1037948897.HKD","SG9999015945.SGD","LU1496350502.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU2471134879.HKD","IE00BJLML261.HKD","LU1035773651.USD","LU0823434583.USD","LU0994945656.USD","LU2750360641.GBP","LU0211331839.USD","LU0942090050.USD","LU0109394709.USD","LU1868836914.USD","LU1066053197.SGD","LU1979441026.SGD","IYH","LU0861579265.USD","IE00B19Z3581.USD","LU1267930730.SGD","LU0053666078.USD","LU2361045086.USD","IE000F7OJYX1.SGD","LU0689472784.USD","LU1941712264.USD","VHT","BK4516","LU2213496289.HKD","IE0009355771.USD","LU2089284900.SGD","IE0000B7K699.USD","LU0980610538.SGD","IE00B3T34201.USD","IE00BN29S564.USD","LU1093756168.USD","SG9999001176.USD","LU0203347892.USD","LU2023250330.USD","LU0545039389.USD","GB00BDT5M118.USD","LU0122379950.USD","IE00BLSP4452.SGD","IE00B3PB1722.GBP","LU2237443382.USD","IE00BGHQF631.EUR","BK4504","LU1699723380.USD","LU1674673428.USD","LU1732799900.SGD","LU0472753341.HKD","LU1059921491.USD","IE00B775H168.HKD","SG9999014559.SGD","LU2602419157.SGD","LU2087625088.SGD","FHLC","LU0124676726.USD","LU0345769128.USD","LU0058720904.USD","IE00BKVL7J92.USD","LU2433249047.HKD","MHIP","IE00BLSP4239.USD","LU1914381329.SGD","LU0210528500.USD","LU0289739343.SGD","LU0786609619.USD","LU2236285917.USD","IE000MB6IJN5.SGD","LU2168564495.EUR","LU0256863811.USD","IE00BFTCPJ56.SGD","IE00B7SZLL34.SGD","LU2357305700.SGD","SG9999014898.SGD","LU1035775433.USD","LU0792757196.USD","LU2023250504.SGD","LU0106261372.USD","LU0889566641.SGD","LU1868836757.USD","IE00BJJMRX11.SGD","LU0471298777.SGD","LU0882574139.USD","IE0002270589.USD","LU1323610961.USD","LU0208291251.USD","SG9999018865.SGD","IE00B1BXHZ80.USD","LU0553294199.USD","IXJ","LU2324357040.USD","LLYX","NVOH","PJP","LU2129689605.HKD","LU0098860793.USD","LU0823416689.USD","LU0795875169.SGD","IE00BSNM7G36.USD","LU0158827948.USD","TMED","IE00BJT1NW94.SGD","LU0471298694.HKD","WDNA","LU2271345857.HKD","SGXZ31699556.SGD","LU1023059063.AUD","LU1988902786.USD","LU1712237335.SGD","SGXZ51526630.SGD","LU0943347566.SGD","IE00BKPKM429.USD","BK4007","LU0203345920.USD","LU0868494617.USD","LU1064131342.USD","LU1061106388.HKD","LU1934455277.USD","LU0320765646.SGD","LU0174119429.USD","SG9999014542.SGD","SG9999013999.USD","JDOC","LU0070302665.USD","LU1232071149.USD","LU2112291526.USD","BK4581","LU1196500208.SGD","LU1720051108.HKD","LU1551013342.USD","LU2462157665.USD","SG9999015986.USD","LU0456855351.SGD","LU0006306889.USD","LU0320765489.SGD","OZEM","LU0672654240.SGD","LU0820562030.AUD","LU2491050071.SGD","LU1934455863.HKD","LU0256863902.USD","LU0385154629.USD","LU1066051225.USD","LU0238689110.USD","LU2168564065.EUR","IE00BK4W5M84.HKD","LU2237438978.USD","LU2471134952.CNY","LU2168564149.EUR","BK4592","LU0738911758.USD","LU2461242641.AUD","LU1032466523.USD","LU0965509101.SGD","LU2468319806.SGD","LU2491050154.USD","LU1868837136.USD","IE000BZT7R73.USD","LU0203201768.USD","LU0109391861.USD","IE00BZ1G4Q59.USD","LU1917777945.USD","LU2756315318.SGD","PPH","LU0234570918.USD","LU0323591593.USD","LU1074936037.SGD","LU2237443622.USD","LU1989772923.USD","SG9999017495.SGD","LU0306807586.USD","LU2750360997.AUD","LU1121112475.USD","LU1127390331.HKD","IE00B19Z3B42.SGD","LU1066051811.HKD","THNR","BK4578","BK4533","SG9999002232.USD","MEDX","IE00B42XCP33.USD","LU0203202063.USD","LU0072461881.USD","SG9999015952.SGD","LU0985320562.USD","LU1983299246.USD","IE00BN8TJ469.HKD","LU0170899867.USD","LU0225771236.USD","LU1894683348.USD","LU0097036916.USD","LU2108987350.USD","BK4599","LU2430703095.HKD","LU0345770308.USD","SG9999015341.SGD","LU0130102774.USD","BK4559","LU0683600562.USD","SG9999002224.SGD","LLY","LU0965509283.SGD","LU0426417589.USD","IE00BBT3K403.USD","LU1116320901.HKD","LU0079474960.USD","LU0225284248.USD","LU0316494557.USD","LU1291159041.SGD","LU0162691827.USD","LU1244550577.SGD","LU1267930813.SGD","LU1043141396.HKD","LU0154236417.USD","SG9999001176.SGD","LU2491049909.HKD","LLII","BK4585","BMED","LU2264538146.SGD","LU2756315664.SGD","LU1732800096.USD","NVOC","LU0661504455.SGD","LU0094547139.USD","LU0289961442.SGD","LU1032955483.USD","IE0004445015.USD","IE000SO60NU8.SGD","LU0823434740.USD","LU1691799644.USD","LU0070217475.USD","LU0466842654.USD","LU1221951129.SGD","LU0345770993.USD","IE000WAW04H5.SGD","LU0061475181.USD","LU1069347547.HKD","IE00B4R5TH58.HKD","GDOC","LU0114720955.EUR","LU1244550221.USD","SG9999003800.SGD","LU2063271972.USD","LU2023251221.USD","LU0985481810.HKD","TRUH","LU0158827781.USD","SG9999014575.USD","LU2125154935.USD","LU1093756325.SGD","LU2462591350.SGD","LU0354030438.USD","LU2360032135.SGD","LU0889565916.HKD","IE00B1XK9C88.USD","LU1201861249.SGD","SG9999014567.USD","SGXZ80539844.SGD","LU0545562505.USD","LU2746668461.USD","LU2596442595.SGD","LU0912757837.SGD","LU2487616109.SGD","LU1043141123.HKD","LU2125154778.USD","LU1571399168.USD","LU1585245621.USD","NVOX","LU1720051017.SGD","IE00BK4W5L77.USD","LU0417517546.SGD","LU1228905540.USD","IE00B4JS1V06.HKD","LU2592432038.USD","LU1221951046.USD","LU0426412945.USD","SG9999015978.USD","LU2552382215.SGD","LU2746668974.SGD","LU0787776722.HKD","IE000M9KFDE8.USD","IE00BVYPNW00.USD","LU2237443549.SGD","LU2129689514.USD","LU0965509010.AUD","PFE","LU2417539215.USD","LU0868494708.USD","LU1929549753.HKD","LU2471134796.USD","LU1506573853.SGD","LU1989771016.USD","LU0964807845.USD","LU1623119135.USD","LU1244550494.USD","LU0306806265.USD","LU1228905037.USD","LU1941712348.USD","LU2430703251.USD","LU2361044865.SGD","IE00BFSS7M15.SGD","LU0265550946.USD","CURE","LU1804176565.USD","LU1718418525.SGD","CANC","LU2403377893.USD","NVO","LU2265009873.SGD","LU2168563687.JPY","IE00BFXG1179.USD","SG9999015358.SGD","LU0354030511.USD","IE00BJJMRY28.SGD","LU0795875086.SGD","SG9999014880.SGD","IE00BWXC8680.SGD","LU0511384066.AUD","LU2430703178.SGD","LU0320765059.SGD","ILDR","LU1261432733.SGD","LU0640476718.USD","IE00B7KXQ091.USD","LU1894683264.USD","LU1116320737.USD","LU2505996681.GBP","IE0034235303.USD","SGXZ57979304.SGD","LU0353189763.USD","LU0096364046.USD","IE00BVYPNV92.GBP","LU0133085943.USD","SG9999018857.SGD","LU1162221912.USD","LU2129689431.USD","AGNG","LU0289739699.SGD","LU1974910355.USD","LU1778281490.HKD","LU1366192091.USD","ELIL","ELIS","LU2211815571.USD","IE00BDGV0183.EUR","LU0689626769.HKD","LU0321505868.SGD","LU1934455194.USD","LU2361044949.HKD","LU2360106947.USD","LU1935042991.SGD","LU2106854487.HKD","LU2028103732.USD","LU0320765992.SGD","LU1868836591.USD","LU2456880835.USD","IE00B2B36J28.USD","IE0005OL40V9.USD","LU0069063385.USD","LU0057025933.USD","BK4568","JNJ","LU1814569148.SGD","LU2237443465.HKD","LU0234572021.USD","BK4588","BK4532","LU1066051498.USD","HRTS","LU0198837287.USD","LU1430594728.SGD","LU0130517989.USD","LU2133065610.SGD","LU2552382132.HKD","IE00BFSS8Q28.SGD","LU0882574055.USD","LU1057294990.SGD","LU0477156953.USD","LU2237443978.SGD","LU2896262040.SGD","LU1923622614.USD","IE0001KFT4U8.USD","LU2505996509.AUD","LU2023250843.SGD","LU2089283258.USD","LU1037948541.HKD","LU2111349929.HKD","SG9999001440.SGD","LU2552382058.USD","LU0265550359.USD","LU0321505439.SGD","LU0225283273.USD","MEDI","FTXH","LU0820561909.HKD","SG9999011175.SGD","LU0820561818.USD","NVS","LU0345769631.USD","LU1883839398.USD","LU1674673691.USD","LU0708995401.HKD","MRK","BK4534","LU0648001328.SGD","LU2089984988.USD","IE0004445239.USD","RXL","LU2168564222.USD","IE00BKDWB100.SGD","SGXZ99366536.SGD","LU2237443895.HKD","LU1551013425.SGD","LU2471134523.USD","LU0353189680.USD","LU2125909593.SGD","PAWZ","SG9999014914.USD","IHE","LU1868837300.USD","LU0859254822.USD","LU0949170772.SGD","LU2357627491.SGD","LU0210536198.USD","LU2125909247.SGD","SGXZ81514606.USD","XLV","BK4550","LU1069344957.HKD","LU1145028129.USD","LU0965508806.USD","LU1548497426.USD","LU1280957306.USD","LU1989772840.SGD","SG9999014906.USD","LU2347655156.SGD","LU1003077747.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669246372","title":"诺和新战略成败取决于一件它无法生产的东西:投资者信任","url":"https://stock-news.laohu8.com/highlight/detail?id=2669246372","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669246372?lang=zh_cn&edition=full","pubTime":"2026-09-24 16:47","pubTimestamp":1790239620,"startTime":"0","endTime":"0","summary":"诺和诺德股价已经明显落后头号对手礼来。诺和诺德计划扩大产能,到 2030 年,口服减重药可服务的肥胖患者规模提升至当前十倍,同期还要推动另外四款口服肥胖新药推向市场。维格威司美格鲁肽口服片剂诺和诺德向投资者表示,多重肥胖治疗药物、强大的口服产品矩阵,叠加糖尿病肥胖以外的新业务板块,将构筑自身竞争优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-24/doc-inisxnvc0348361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVOH","BK4585","BK4532","BK4007","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0154236417.USD","NVO","NVOC","NVOX","OZEM","BK4588","LU1093756325.SGD","BK4599","THNR","LU1093756168.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669570944","title":"A股节前全天缩量震荡 深成指收跌2.34% 减肥药、电子烟板块疲软","url":"https://stock-news.laohu8.com/highlight/detail?id=2669570944","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669570944?lang=zh_cn&edition=full","pubTime":"2026-09-24 15:11","pubTimestamp":1790233888,"startTime":"0","endTime":"0","summary":"金吾财讯 | A股中秋节前全天缩量震荡,午后跌幅进一步扩大,整体交投情绪继续下降,截至收盘,沪指跌1.22%,深成指跌2.34%,创业板指跌2.68%。板块方面,先进封装、减肥药、CPO、电子烟等板块跌幅居前;教育、航运港口、煤炭、工程机械等板块涨幅居前。国投证券表示,若节前成交不足,行情仍需依靠部分行业和个股带动。偏债转债的纯债溢价率仍低于2021至2023年的中枢,但上周已由12.3%回升至13.0%,110只低平价样本中仅13只到期收益率为正。","market":"hk","thumbnail":"https://static.szfiu.com/news/20200915/NzYyNDljMmIwNjZjMTQ3MTljY2ZkYmY1MDAwNDcwMjMxMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NzYyNDljMmIwNjZjMTQ3MTljY2ZkYmY1MDAwNDcwMjMxMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1992454","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399001","02827","06969","BK1589","NVOH","PINK","399300","83130","07233","NVOX","159982","NVOC","FHLC","03130","BK1147","NBDS","TRUH","THNR","02846","CURE","83188","MEDI","03188","IYH","BK1242","XLVI","PJP","RSPH","82846","BK1580","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669748604","title":"诺和诺德(NVO)瞄准脱发市场 推进后Wegovy多元化增长战略","url":"https://stock-news.laohu8.com/highlight/detail?id=2669748604","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669748604?lang=zh_cn&edition=full","pubTime":"2026-09-23 21:08","pubTimestamp":1790168913,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德(NVO)正考虑布局脱发治疗赛道。作为Ozempic、Wegovy的研发药企,公司将探索脱发领域作为“后Wegovy”增长战略的一部分,谋求业务多元化。诺和诺德首席科学官Martin Lange表示,公司可依托自身科研能力切入脱发领域。他同时称,脱发项目不一定是优先推进的方向,但属于明确的潜在机会。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/NzFhNTI4MGUwYzI0YmU3ZWQ0MDcxNDc2MTkyOTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NzFhNTI4MGUwYzI0YmU3ZWQ0MDcxNDc2MTkyOTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306397","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4588","LU1093756168.USD","LU0154236417.USD","NVOC","NVOH","LU1093756325.SGD","BK4599","NVOX","THNR","OZEM","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVO","BK4585","BK4007","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669762483","title":"字节、百度与恒瑞、诺和诺德,抢滩AI制药商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2669762483","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669762483?lang=zh_cn&edition=full","pubTime":"2026-09-23 20:01","pubTimestamp":1790164907,"startTime":"0","endTime":"0","summary":"截图来源于港股公告叠加字节跳动将AI制药业务独立拆分设立Anew Labs这一动作,入局AI制药的大厂阵营还在持续扩容。目前,行业已有落地成果佐证AI的前端价值。港股龙头英硅智能的发展路径,展现了当前AI药企的部分商业化现状。截图来源于港股公告这份增速亮眼的财报,证明AI技术具备即时商业变现能力。AI技术模型可以加快新药研发的起点,但从这条赛道跑出来的玩家,大概率是率先实现临床转化与商业化落地的那个。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789979347715387090","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4574","BK0028","LU2488822045.USD","LU2097828631.EUR","IE00B0JY6N72.USD","LU0359201612.USD","LU0359202008.SGD","LU0405327148.USD","NVOH","BK4548","LU1781817850.SGD","BK4579","BK0239","BK4526","LU1969619763.USD","01276","LU1328615791.USD","BIDU","LU1997245094.SGD","BK4599","BK0188","BK4552","LU0405327494.USD","BK4602","LU2580892862.HKD","BK4504","LU2495084118.USD","THNR","LU0173614495.USD","LU1255011170.USD","LU2328871848.SGD","LU1093756168.USD","LU1023057109.AUD","BK4007","BK4532","LU2289578879.USD","BK0196","BK4543","BK4077","LU1146622755.USD","LU1093756325.SGD","LU2097828557.USD","02257","IE00BZ1G4Q59.USD","LU0640798160.USD","LU2148510915.USD","NVOX","PPH","BK4585","BIDG","BK0060","LU2097828805.USD","600276","LU1655091616.SGD","09888","LU1580142542.USD","LU2580892789.USD","BK4587","BK4535","LU2097828474.EUR","LU0154236417.USD","DRGN","LU1115378108.SGD","OZEM","KBDU","NVOC","LU1064131003.USD","BK4614","BK4588","BK4514","LU0287142896.SGD","BK1161","IE00BKVL7J92.USD","LU1064130708.USD","BK4531","LU2097828714.EUR","BK4612","LU1997245177.USD","LU1820825898.SGD","LU1997244956.HKD","NVO","BK0183","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106047860","title":"诺和诺德考虑改变美股上市方式:拟告别ADR、直接登陆纽交所","url":"https://stock-news.laohu8.com/highlight/detail?id=1106047860","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106047860?lang=zh_cn&edition=full","pubTime":"2026-09-23 15:28","pubTimestamp":1790148494,"startTime":"0","endTime":"0","summary":"诺和诺德正考虑改变美国投资者持有公司股票的方式,以进一步提升其在华尔街的影响力。","market":"us","thumbnail":"https://community-static.tradeup.com/news/7b57cba2d68c92ee95b1cc87b70c41f0","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7b57cba2d68c92ee95b1cc87b70c41f0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德考虑改变美股上市方式:拟告别ADR、直接登陆纽交所","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","NVOX","NVOH","NVOC"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2669172514","title":"诺和诺德对升级其纽约上市地位的想法持开放态度,这是这家丹麦减肥药制造商提升其在美国知名度努力的一部分,其英国竞争对手阿斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2669172514","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669172514?lang=zh_cn&edition=full","pubTime":"2026-09-23 12:15","pubTimestamp":1790136902,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IYH","PINK","TRUH","IPOS","CURE","BGIA","NVOX","MEDI","NVOH","FXH","PJP","NBDS","XLVI","RSPH","NVOC","FHLC","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142648","title":"Viking Therapeutics涨超35%!减肥药传来捷报:给药频率减半仍维持97%减重","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142648","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669142648?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:50","pubTimestamp":1790085009,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,Viking Therapeutics周二盘前一度飙升近50%,此前这家生物科技公司宣布,其实验性肥胖症药物VK2735帮助患者在用药频率从每周一次降至每两周一次的情况下,仍维持了大部分减重成果。这一结果有望进一步增强VK2735在快速扩张的减肥药市场中的竞争地位。截至发稿,VKTX股价上涨近23%。今年以来,该股累计下跌约15%。据了解,VK2735是Viking的主要肥胖症候选药物,正在开发注射剂和口服剂两种剂型。","market":"fut","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499522.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PINK","BK4139","RSPH","BK4588","XLVI","NVOH","CURE","NVOX","TRUH","PJP","NVOC","FXH","MEDI","BK4585","NBDS","IYH","FHLC","BK4599","OZEM","VKTX","BK4007","LENZ","THNR","BK4539"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2669476381","title":"诺和诺德CEO:对收购持开放态度,以强化减重药物管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2669476381","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669476381?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:26","pubTimestamp":1790083566,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["NVOX","NVOC","OZEM","BGIA","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669987110","title":"诺和诺德资本市场日遇冷:CEO坦言承诺太多、兑现不足,必须重建投资者信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2669987110","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669987110?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:13","pubTimestamp":1790082780,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,诺和诺德首席执行官迈克·杜斯塔尔周二在一次采访中表示,公司必须付出更多努力来重建投资者信心,因为这家Ozempic制造商旗下最大药物将在下一个十年初面临专利悬崖。诺和诺德股价周一出现下挫,因为这家丹麦制药公司的资本市场日让投资者对其转型计划的细节缺失感到失望。诺和诺德承诺到2030年推出五款以上重磅新药,到2035年新增销售额超过230亿美元。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499312.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NVOH","NVO","NVOX","NVOC","BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669110867","title":"诺和诺德(NVO)CagriSema减重效果胜过礼来(LLY)低剂量Zepbound","url":"https://stock-news.laohu8.com/highlight/detail?id=2669110867","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669110867?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:58","pubTimestamp":1790067492,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德 公布Ⅲ期临床试验结果,其在研每周一次肥胖症疗法CagriSema,对比竞争对手礼来每周注射剂Zepbound5mg剂量,取得更佳减重效果。REIMAGINE 5试验入组2型糖尿病成人患者,第60周数据显示,CagriSema 1mg/1mg预估平均减重12.4%,Zepbound组减重9.1%;CagriSema降低HbA1c的效果同样达到对Zepbound的非劣效标准。在针对超重、肥胖患者的REDEFINE 9试验中,CagriSema组减重21%,安慰剂组减重2%,该项研究未设置Zepbound对照。tirzepatide还由礼来以Mounjaro商品名用于2型糖尿病治疗,剂量范围相同。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/OTc4NDY1YzgwYTY5ZDI5OGQwMTAxMzU2NDM1Mjg5Ng==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/OTc4NDY1YzgwYTY5ZDI5OGQwMTAxMzU2NDM1Mjg5Ng==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306310","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382215.SGD","LU2023250504.SGD","FHLC","LU2108987350.USD","LU1069344957.HKD","SGXZ81514606.USD","IE00BJJMRZ35.SGD","IE00B1BXHZ80.USD","LU2089283258.USD","VHT","TMED","LU0345770993.USD","LU0787776722.HKD","LU2023250330.USD","LU2471134796.USD","ELIS","NVOH","XLV","IE0004445239.USD","LU1868837300.USD","IHE","LU0109394709.USD","LU1267930730.SGD","IE00BK4W5L77.USD","LU0353189680.USD","LU2089984988.USD","LU0289739699.SGD","LU2023251221.USD","MHIP","OZEM","LU0466842654.USD","LU2552382058.USD","IE00B775H168.HKD","LLYX","SG9999014906.USD","LU0096364046.USD","LU1548497426.USD","LU0061475181.USD","LU1868836914.USD","LU0640476718.USD","IE00B2B36J28.USD","LU2168564222.USD","LU2168564495.EUR","SG9999018865.SGD","SGXZ31699556.SGD","LU2462157665.USD","LU0097036916.USD","LU0417517546.SGD","LU0354030511.USD","IE0005OL40V9.USD","LU0109391861.USD","LU1064131342.USD","BK4516","LU2471134523.USD","LU2552382132.HKD","LU0456855351.SGD","IE00BFSS7M15.SGD","LU1366192091.USD","IE0002141913.USD","LU1551013342.USD","LLII","LU0943347566.SGD","LU0058720904.USD","LU0823434740.USD","LU0256863902.USD","LU2028103732.USD","LU1035775433.USD","IE00BWXC8680.SGD","LU0471298777.SGD","LU1127390331.HKD","IE00BKDWB100.SGD","LU2471134879.HKD","RXL","LU2087625088.SGD","LU2357305700.SGD","LU1061106388.HKD","LU2602419157.SGD","IE00BFSS8Q28.SGD","LU1232071149.USD","LU0114720955.EUR","LU1623119135.USD","LU0320765059.SGD","LU2491050071.SGD","LU2360106947.USD","LU0683600562.USD","LU0266013472.USD","LU2896262040.SGD","LU0154236417.USD","LU1720051108.HKD","SG9999014898.SGD","LU0256863811.USD","LU1291159041.SGD","SG9999014880.SGD","LU2324357040.USD","LU2750360641.GBP","SG9999001176.SGD","IE00B4JS1V06.HKD","IE00BFTCPJ56.SGD","LU0708995401.HKD","LU0820561909.HKD","SG9999014914.USD","LU0882574055.USD","LU2237438978.USD","IE00BZ1G4Q59.USD","LLYZ","IE00BJJMRY28.SGD","LU0882574139.USD","GB00BDT5M118.USD","IE00BKVL7J92.USD","BK4585","LU1093756325.SGD","LU1983299246.USD","LU2237443978.SGD","MEDX","CURE","LU2756315318.SGD","LU0203201768.USD","LU2211815571.USD","SG9999015945.SGD","TRUH","BK4533","LU0210536198.USD","LU2750360997.AUD","LU0889565916.HKD","LU0820562030.AUD","IE0004445015.USD","LU0158827781.USD","SG9999001176.USD","IE00B1XK9C88.USD","LU2112291526.USD","BK4534","LU2237443465.HKD","IE00BK4W5M84.HKD","IE00BN29S564.USD","WDNA","CANC","SG9999017495.SGD","LU1988902786.USD","LU0471298694.HKD","LU1974910355.USD","LU0006306889.USD","LU0122379950.USD","LU0238689110.USD","LU0385154629.USD","LU1629891620.HKD","LU1145028129.USD","LU1917777945.USD","LU1989771016.USD","LU2237443622.USD","SG9999015952.SGD","LU2168563687.JPY","LU1868836591.USD","LU1280957306.USD","LU0198837287.USD","LU2491049909.HKD","IE0001KFT4U8.USD","LU2264538146.SGD","LU2462591350.SGD","LU1057294990.SGD","ELIL","LU1691799644.USD","LU0823416689.USD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","LU0345770308.USD","IE0009355771.USD","LU0158827948.USD","LU0689472784.USD","LU2089284900.SGD","LU2111349929.HKD","LU2361045086.USD","SGXZ99366536.SGD","LU0079474960.USD","LU1093756168.USD","LU2237443895.HKD","IE00BJLML261.HKD","LU1551013425.SGD","SG9999015986.USD","FTXH","LU2461242641.AUD","LU0106261372.USD","LU2237443549.SGD","LU0786609619.USD","GDOC","NVO","LU0353189763.USD","IYH","LU0323591593.USD","LU2213496289.HKD","LU0234572021.USD","BK4588","LU1804176565.USD","LU1868837136.USD","LU0820561818.USD","LU2237443382.USD","BK4532","LU2265009873.SGD","LU0133085943.USD","LU0316494557.USD","SG9999013999.USD","LU2456880835.USD","LU2361044949.HKD","LU0320765992.SGD","HRTS","LU2063271972.USD","NVOX","LU0174119429.USD","BK4007","IXJ","LU1023059063.AUD","LU2468319806.SGD","LU2746668461.USD","NVOC","LU0354030438.USD","LU2106854487.HKD","LU0672654240.SGD","IE00B7KXQ091.USD","LU1720051017.SGD","MEDI","PJP","LU2471134952.CNY","JDOC","LLY","LU0094547139.USD","LU1979441026.SGD","LU2168564149.EUR","LU0964807845.USD","LU1323610961.USD","LU0225283273.USD","ILDR","LU1814569148.SGD","LU0432979614.USD","LU2491050154.USD","PPH","SG9999015978.USD","SG9999018857.SGD","LU2361044865.SGD","BK4599","LU2756315664.SGD","AGNG","IE00BKPKM429.USD","LU2271345857.HKD","LU1712237335.SGD","LU2236285917.USD","SGXZ51526630.SGD","LU0203202063.USD","LU1868836757.USD","LU2746668974.SGD","LU2417539215.USD","LU2168564065.EUR","IE00BJJMRX11.SGD","BK4581","IE00BJT1NW94.SGD","THNR","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669685119","title":"诺和诺德CEO:正在成瘾等领域测试GLP-1药物。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669685119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669685119?lang=zh_cn&edition=full","pubTime":"2026-09-22 14:39","pubTimestamp":1790059169,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOC","THNR","NVOX","JDOC","MEDI","BGIA","RSPH","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669633164","title":"减肥药巨头,裁掉了1.3万个岗位","url":"https://stock-news.laohu8.com/highlight/detail?id=2669633164","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669633164?lang=zh_cn&edition=full","pubTime":"2026-09-21 23:20","pubTimestamp":1790004000,"startTime":"0","endTime":"0","summary":"诺和诺德方面表示,通过本轮组织调整,公司节约成本超100亿丹麦克朗,帮助公司重新投向商业化与研发;过往调整累计涉及约1.3万个岗位,目前全球全职员工为6.6万人。2026年上半年,诺和诺德司美格鲁肽产品组合,合计销售额为1121.93亿丹麦克朗,收入已落后竞品礼来的替尔泊肽约102亿美元。在这一阶段,竞争格局将达到顶峰,企业需要在专利到期的司美格鲁肽与下一代肥胖治疗药物之间进行战略定位。本次资本日,诺和诺德公布了2030战略雄心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-09-21/doc-inisrhfv9159432.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-21/doc-inisrhfv9159432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVOH","PJP","THNR","NVOX","XLVI","FXH","RSPH","MEDI","TRUH","PINK","NVOC","FHLC","IYH","CURE","NBDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669318161","title":"减肥药巨头诺和诺德本轮调整,裁掉了1.3万个岗位","url":"https://stock-news.laohu8.com/highlight/detail?id=2669318161","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669318161?lang=zh_cn&edition=full","pubTime":"2026-09-21 22:08","pubTimestamp":1789999702,"startTime":"0","endTime":"0","summary":"去年9月份宣布要裁员9000人的诺和诺德,于9月21日在伦敦举办的资本市场日上披露了最终减员情况。诺和诺德方面表示,通过本轮组织调整,公司节约成本超100亿(15.35亿美元)丹麦克朗,帮助公司重新投向商业化与研发;过往调整累计涉及约1.3万个岗位,目前全球全职员工为6.6万人。诺和诺德本轮人员优化背后,核心动因是支撑公司七成以上营收的王牌产品司美格鲁肽,正面临增长承压的挑战。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609213880315953.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609213880315953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["XLVI","FXH","NBDS","PINK","TRUH","NVOC","MEDI","THNR","IYH","NVOX","FHLC","PJP","RSPH","BGIA","CURE","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669728150","title":"诺和诺德(NVO)跌4.81% 司美格鲁肽被关联罕见致盲眼疾","url":"https://stock-news.laohu8.com/highlight/detail?id=2669728150","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669728150?lang=zh_cn&edition=full","pubTime":"2026-09-21 19:13","pubTimestamp":1789989235,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德 美股盘前股价承压,最新跌4.81%,报41.15美元。司美格鲁肽是用于2型糖尿病治疗、可辅助减重的处方药,被称作“减肥神药”,近年在全球热销,其潜在副作用持续受到市场关注。该患者服用司美格鲁肽治疗2型糖尿病长达6个月,医生已要求其立刻停药,保护剩余视力。部分医生研究认为,司美格鲁肽或令NAION发病风险提升约一倍;欧洲药品管理局将其列为极罕见副作用,预估万人中最多1例发病。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/MGY3NWNiZjgxNDI5NTMwNTcxNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MGY3NWNiZjgxNDI5NTMwNTcxNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306274","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK4007","PPH","THNR","BK4585","BK4599","BK4588","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVOC","NVOH","NVO","NVOX","OZEM","LU1093756168.USD","LU0154236417.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669723157","title":"诺和诺德再向礼来“宣战”!CagriSema头对头胜过替尔泊肽,减重12.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669723157","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669723157?lang=zh_cn&edition=full","pubTime":"2026-09-21 19:02","pubTimestamp":1789988564,"startTime":"0","endTime":"0","summary":"诺和诺德公布旗下减重药CagriSema最新临床数据:在与礼来替尔泊肽的直接比较中,CagriSema平均减重12.4%,高于替尔泊肽的9.1%;另一项试验中减重达21%。目前该药已提交FDA审批,预计今年第四季度迎来结果。","market":"sh","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3782221","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"诺和诺德再向礼来“宣战”!CagriSema头对头胜过替尔泊肽,减重12.4%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","NVO","NVOC","BGIA","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669759159","title":"注射明星减肥药或导致失明?礼来和诺和诺德两巨头在美遭患者起诉","url":"https://stock-news.laohu8.com/highlight/detail?id=2669759159","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669759159?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:54","pubTimestamp":1789980888,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA","PINK","FHLC","IYH","CURE","NVOC","NVOX","PJP","TRUH","XLVI","THNR","NVOH","NBDS","FXH","RSPH","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669590351","title":"注射明星减肥药或导致失明?礼来和诺和诺德两巨头在美遭患者起诉","url":"https://stock-news.laohu8.com/highlight/detail?id=2669590351","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669590351?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:53","pubTimestamp":1789980780,"startTime":"0","endTime":"0","summary":"一起美国的诉讼,让GLP-1药物的安全性再次受到行业关注。据外媒报道称,自2025年以来,一律所代表患者在美国新泽西州州法院提起了90多起诉讼,其起诉的对象是明星GLP-1药物司美格鲁肽背后的药企诺和诺德,原因是其在使用降糖版司美格鲁肽之后被诊断为非动脉炎性前部缺血性视神经病变(简称NAION)。上述报道指出,礼来的GLP-1药物替尔泊肽也面临患者针对NAION风险提起的诉讼。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609213880057798.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609213880057798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["FXH","FHLC","TRUH","IYH","NVOH","NVOX","CURE","RSPH","BGIA","MEDI","XLVI","THNR","NBDS","PINK","PJP","NVOC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.2044},{"period":"1month","weight":-0.3442},{"period":"3month","weight":-0.3881},{"period":"6month","weight":0.0636},{"period":"1year","weight":-0.6592},{"period":"ytd","weight":-0.5491}],"compareEarnings":[{"period":"1week","weight":0.0127},{"period":"1month","weight":0.0069},{"period":"3month","weight":0.0581},{"period":"6month","weight":0.2165},{"period":"1year","weight":0.1722},{"period":"ytd","weight":0.1311}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"ARCA","name":"2倍做多NVO ETF-Defiance","nameEN":"Defiance Daily Target 2X Long NVO ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供2倍做多NVO ETF-Defiance(NVOX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"2倍做多NVO ETF-Defiance,NVOX,2倍做多NVO ETF-Defiance股票,2倍做多NVO ETF-Defiance股票老虎,2倍做多NVO ETF-Defiance股票老虎国际,2倍做多NVO ETF-Defiance行情,2倍做多NVO ETF-Defiance股票行情,2倍做多NVO ETF-Defiance股价,2倍做多NVO ETF-Defiance股市,2倍做多NVO ETF-Defiance股票价格,2倍做多NVO ETF-Defiance股票交易,2倍做多NVO ETF-Defiance股票购买,2倍做多NVO ETF-Defiance股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供2倍做多NVO ETF-Defiance(NVOX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}